Juul cofounder James Monsees plans to leave the company. Monsees currently serves as an adviser and board member. Juul’s other cofounder Adam Bowen will remain with the company. (Bloomberg)

A study has found that the median incubation period for COVID-19 is five days. The research used data from news reports and press releases from affected areas outside Wuhan, China. The study also found that 97% of those who develop symptoms do so within about 11 days of infection. (Pulmonology Advisor)

Lawmakers are struggling to agree on coronavirus response. Republicans called a bill introduced by Democrats “unworkable.” That bill would expand paid sick leave, unemployment benefits and food benefits, along with offering free testing for COVID-19. (Reuters)

CureVac, a biotech working on a COVID-19 vaccine, has replaced its CEO. Daniel Menichella who served as chief executive will be replaced by board chairman Ingmar Hoerr. The company is one of about a dozen working on a vaccine. (BioPharma Dive)

Vir Biotechnology is partnering with Biogen for a COVID-19 treatment. Biogen gives Vir, a smaller biotech, more manufacturing capability to mass-produce a potential treatment. (BioPharma Dive)